T cell receptor-Influenza Hemagglutinin peptide-MHC complex (TCR-HA-pMHC)

The T cell receptor-Influenza Hemagglutinin peptide-MHC complex (TCR-HA-pMHC) is a fundamental molecular assembly that mediates the adaptive immune system's recognition of the influenza virus. This complex forms when a T cell receptor (TCR) on the surface of a T lymphocyte binds to a specific peptide derived from the influenza hemagglutinin (HA) protein, which is presented by a Major Histocompatibility Complex (MHC) molecule on an antigen-presenting cell [Stern et al., 1994]. A classic example is the recognition of the immunodominant HA 306-318 epitope by CD4+ T cells when presented by HLA-DR4, a process central to generating protective immunity [Hennecke & Wiley, 2002]. This interaction serves as the primary signal for T cell activation, leading to the expansion of virus-specific T cells and the production of antiviral cytokines such as interferon-gamma. In clinical medicine, this complex is the target of various influenza vaccines which aim to prime this recognition, and it is also being explored for TCR-engineered T cell therapies to provide broad protection against diverse flu strains [Batalia & Collins, 1997]. Understanding the structural nuances of this interaction is vital for overcoming challenges such as viral antigenic drift and ensuring the specificity of the immune response to avoid cross-reactivity with host tissues [Wucherpfennig, 2001].

Other names

TCR-HA-HLA complexInfluenza HA-specific T cell receptorHA306-318/HLA-DR4 complexHemagglutinin peptide-MHC-TCR complexTCR-pMHC complex (Influenza HA)

The TCR-HA-pMHC complex functions by facilitating the physical interaction between a T lymphocyte and an antigen-presenting cell, where the TCR binds specifically to the HA peptide nestled within the MHC groove. This binding event triggers the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) on the associated CD3 complex, initiating an intracellular signaling cascade through ZAP-70 and Lck kinases that leads to T cell activation, proliferation, and effector functions [Hennecke & Wiley, 2002; Stern et al., 1994].